Pfizer's Celebrex, Bextra Ads Strike Wrong Chord With FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency cites COX-2 inhibitor promotions, including a reminder ad showing a guitarist playing "the long version" of a song thanks to Celebrex. The agency says the violations would have warranted a warning letter if not for Pfizer's previous agreement to halt Celebrex advertising.
You may also be interested in...
Pfizer Zoloft Ad Cited By FDA For Omitting Suicide Risk
FDA's ad review division objects to an October print ad for the antidepressant that failed to mention the risk of suicidality and clinical worsening. The ad's brief summary referenced information from outdated labeling, the agency says.
Pfizer Zoloft Ad Cited By FDA For Omitting Suicide Risk
FDA's ad review division objects to an October print ad for the antidepressant that failed to mention the risk of suicidality and clinical worsening. The ad's brief summary referenced information from outdated labeling, the agency says.
State AGs Should Establish DTC Review Group, Public Citizen's Wolfe Says
An independent commission could analyze select drug advertisements to consider action by state prosecutors, Public Citizen Health Research Group Director Sid Wolfe tells the National Association of Attorneys General conference.